Vol 21. N°2. 2020  |  Abril-Junio de 2020


NUTRICIÓN


IMPORTANCIA DE LA LECHE Y SUS POTENCIALES EFECTOS EN LA SALUD HUMANA


Autores: MARTA ALICIA SÁNCHEZ, RAÚL SANDRO MURRAY, JULIO MONTERO, MARIANO MARCHINI, ROCÍO IGLESIAS, GABRIELA SAAD


RESUMEN

El Código Alimentario Argentino establece: ""Con la denominación de leche sin calificativo alguno, se entiende el producto obtenido por el ordeño total e ininterrumpido, en condiciones de higiene, de la vaca lechera en buen estado de salud y alimentación, proveniente de tambos inscriptos y habilitados por la Autoridad Sanitaria Bromatológica Jurisdiccional y sin aditivos de ninguna especie""1. La leche de vaca es un componente cuantitativamente útil en la alimentación humana en gran parte debido al acceso generalizado a partir de su industrialización y comercialización. Su composición la hace de interés para adaptar su uso y prescripción en distintos momentos de la vida y en la promoción de la salud. Según estudios de investigación, los efectos no se limitarían exclusivamente a su valor nutricional, sino que sumarían otros potenciales en determinadas patologías como la enfermedad cardiovascular, algunos tipos de cáncer, hipertensión arterial, en patología ósea o dental y en la lucha frente al sobrepeso y la obesidad. Por este motivo, el Grupo de Trabajo Alimentos de la Sociedad Argentina de Nutrición realizó esta revisión sobre los potenciales efectos de la leche: virtuosos o adversos.

Palabras clave: leche; efectos potenciales.

REFERENCIAS:
1. Código Alimentario Argentino. Artículo 554, Resolución 22, 30/01/95. Disponible en: https://www.argentina.gob.ar/anmat/codigoalimentario.
2. Severin S, Wenshui X. Milk biologically active components as nutraceuticals: review. Crit Rev Food Sci Nut 2005; 45:645-646.
3. Torres-Llanez MJ, Vallejo-Cordoba B, González-Córdova AF. Péptidos bioactivos derivados de las proteínas de la leche. ALAN 2005; Vol 55, Nº 2.
4. Zivkovic AM, Barile D. Bovine milk as a source of functional oligosaccharides for improving human health. Adv Nutr 2011; 2:284-289.
5. Benjamin S, Spencer F. Conjugated linoleic acids as functional food: an insight into their health benefits. Nutr Metab (Lond) 2009; 6:36.
6. Uscanga-Domínguez LF, Orosco-García IJ, Vázquez-Frías R, et al. Posición técnica sobre la leche y derivados lácteos en la salud y en la enfermedad del adulto de la Asociación Mexicana de Gastroenterología y la Asociación Mexicana de Gerontología y Geriatría. Revista de Gastroenterología de México 2019; 84(3): 357-371.
7. Rice BH, Quann EE, Miller GD. Meeting and exceeding dairy recommendations: effects of dairy consumption on nutrient intakes and risk of chronic disease. Nutr Rev 2013; 71: 209-23.
8. Shin K, Yamauchi K, Teraguchi S, Hayasawa H, Tomita M, Otsuka Y, Yamazaki S. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli 0157:H7. Lett Appl Microbiol 1998; 6:407-411.
9. Lahov E, Regelson W. Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem Toxicol 1996; 34:131-145 10. Clare A, Swaisgood H. Bioactive milk peptides: a prospectus. Journal of Dairy Science 2000; Vol 83, Issue 6: 1187-1195.
11. Chatterton D, Smithers G, Roupas P, Brodkorb A. Bioactivity of ?-lactoglobulin and ?-lactalbumin technological implications for processing. Int Dairy J 2006; 16: 1229-40.
12. Virtanen T, Pihlanto A, Akkanen S, Korhonen H. Development of antioxidant activity in milk whey during fermentation with lactic acid bacteria. J Appl Microbiol 2007; 102: 106-15.
13. Erdmann K, Cheung B, Schroder H. The possible roles of foodderived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem 2008; 19: 643-54.
14. Thomä-Worringer C, Sorensen J, López-Fandiño R. Health effects and technological features of caseinomacropeptide. Int Dairy J 2006; 16:1324-33.
15. Fiat AM, Migliore-Samour D, Jolles P, Drouet L, Bal dit Sollier C, Caen J. Biologically active peptides from milk with emphasis on two examples concerning antithrombotic and immunomodulating activities. J Dairy Sci 1993; 76:301-310.
16. Jolles P, Levy-Toledano S, Fiat AM, Soria C, Gillesen D, Thomaidis A, Dunn FW, Caen JP. Analogy between fibrinogen and casein: effect of an undecapeptide isolated from k-casein on platelet function. Eur J Biochem 1986; 158:379-384.
17. Jolles P, Henschen A. Comparison between the clotting of blood and milk. Trends Biochem Sci 1982; 7:325-328.
18. Mazoyer E, Bal Dit Sollier C, Drouet L, Fiat AM, Jollet P, Caen J. Active peptides from human and cow's milk proteins effects on platelets function and vessel wall. En: Foods Nutrition and Immunity. Vol 1, Dyn Nutr Res Basel Karger 1992: 88-95.
19. Fiat AM, Jolles P. Caseins of various origins and biologically active casein peptides and oligosaccharides: structural and physiological aspects. Mol Cell Biochem 1989; 87:5-30.
20. Chabance B, Qian ZY, Migliore-Samour D, Jolles P, Fiat AM. Binding of the bovine caseinoglycopeptide to the platelet membrane glycoprotein GPIb alpha. Biochem Mol Biol Int 1997; 42:77-84.
21. Chabance B, Jolles P, Izquierdo C, Mazoyer E, Francoual C, Drouet L, Fiat AM. Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion. Br J Nutr 1995; 73:583-590.
22. Adegboye AR, Christensen LB, Holm-Pedersen P, Avlund K, Boucher BJ, Heitmann BL. Intakes of calcium, vitamin D, and dairy serving and dental plaque in older Danish adults. Nutr J 2013; 16:61.
23. Nakamura Y, Yamamoto N, Sakai K, Okubo A, et al. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 1995; 78: 777-783.
24. Nakamura Y, Yamamoto N, Sakai K, Takno T. Antihypertensive effect of sour milk and peptides isolated from it are inhibitors to angiotensin-converting enzyme. J Dairy Sci 1995; 78:1253-1257.
25. Yamamoto N. Antihypertensive peptides derived from food proteins. Biopolymers 1997; 43:129-134.
26. Kohmura M, Nio N, Kubo K, Minoshima Y, Munekata E, Ariyoshi Y. Inhibition of angiotensin I-converting enzyme by synthetic peptides of human ?-casein. Agric Biol Chem 1989; 53:2107-2114.
27. Kohmura M, Nio N, Ariyoshi Y. Inhibition of angiotensin I-converting enzyme by synthetic peptides of human k-casein. Agric Biol Chem 1990; 54:835-836.
28. Meisel M, Schlimme E. Inhibitors of angiotensin I-converting enzyme derived from bovine casein (casokinins). Brantl V, Teschemacher H (Eds.), ?-Casomorphins and related peptides: recent developments, VCH-Weinheim, Germany (1994), pp. 27-33.
29. Murakami M, Tonouchi H, Takahashi R, Kitazawa H, Kawai Y, Negishi H, et al. Structural analysis of a new anti-hypertensive peptide (?-lactosin B) isolated from a commercial whey product. J Dairy Sci 2004; 87:1967-74.
30. Otte J, Shalaby S, Zakora M, Nielsen M. Fractionation and identification of ACE-inhibitory peptides from a-lactalbumin and bcasein produced by thermolysin-catalysed hydrolysis. Int Dairy J 2007; 17: 1460-72.
31. Vinderola G, de LeBlanc A, Perdigón, G, Matar C. Biologically active peptides released in fermented milk: role and functions. En: Farnworth E, editor. Handbook of fermented funcional foods.
32. Abubakar A, Saito T, Kitazawa H, et al. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase k digestion. J Dairy Sci 1998; 81: 3131-38.
33. Hartmann R, Meisel H. Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol 2007; 18:163-69.
34. Hernández-Ledezma B, Recio I, Amigo L. ?-lactoglobulin as source of bioactive peptides. Amino Acids 2008; 35: 257-65.
35. Lignitto L, Cavatorta V, Balzan S, Gabai G, Galaverna G, et al. Angiotensin-converting enzyme inhibitory activity of watersoluble extracts of asiago d'allevo cheese. Int Dairy J 2010; 20:11-17.
36. Mullally M, Meisel MH, FitzGerald RJ. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin. FEBS Lett., 402 1997; 99-101.
37. Ralston RA, Lee JH, Truby H, Palermo CE, Walker KZ. A systematic review and meta-analysis of elevated blood pressure an consumption of dairy foods. J Hum Hypertens 2012; 26: 3-13.
38. Kayser H, Meiser H. Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Letters 1996; 383:18-20.
39. LeBlanc J, Matar C, Valdéz J, LeBlanc J, et al. Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J Dairy Sci 2002; 85: 2733-42.
40. Mercier A, et al. Immunomodulating effects of whey proteins and their enzymatic digests. Int Dairy J 2004; 14: 175-83.
41. Saint-Sauveur D, Gauthier S, Boutin Y, Montoni A. Immunomodulating properties of a whey protein isolate, its enzymatic digest and peptide fractions. Int Dairy J 2008; 18:260-70.
42. Nielsen, Søren Drud, Robert L. Beverly, Yunyao Qu, David C. Dallas. Milk bioactive peptide database: a comprehensive database of milk protein-derived bioactive peptides and novel visualization. Food Chemistry 2017 Oct; 232.
43. Martínez de Victoria E. El calcio, esencial para la salud. Nutr Hosp 2016; Vol 33 supl. 4, Madrid.
44. Thorning TK, Raben A, et al. Milk and dairy products: good or bad for human health? An assessment of the totaly of scientific evidence. Food Nutr Res 2016; 22.
45. Willett WC, Ludwig DS. Milk and health. N Engl J Med 2020; 382: 644-54.
46. Fardellone P, Séjourné A, Blain H, Cortet B, Thomas T; GRIO Scientific Committee. Osteoporosis: Is milk a kindness or a curse? Joint Bone Spine 2017 May; 84(3) 275-281.
47. Kattah W. Epidemiología de la osteoporosis: algunos datos demográficos de la población mundial. Revista Colombiana de Menopausia. Menopausia 01 N° 2. Disponible en: https:// encolombia.com/medicina/revistas-medicas/menopausia/vm- 12/meno1295-osteoporosisepidemiologia/.
48. González-Sanz AM, González-Nieto BA, González-Nieto E. Salud dental: relación entre la caries dental y el consumo de alimentos. Nutr Hosp 2013; 28 (Supl 4): 64-71.
49. Ravishankar TL, Yadav V, Tangade PS, Tirth A, Chaitra TR. Effect of consuming different dairy products on calcium, phosphorus and pH leve lof human dental plaque: a comparative study. Eur Arch Paediatr Dent 2012; Jun 13(3): 144-148.
50. Telgi RL, Yadav V, Telgi CR, Boppana N. In vivo dental plaque pH after consumption of dairy products. Gen Dent 2013 MayJun; 61(3): 56-9.
51. Fernández-Fernández E, Martínez-Hernández JA, MartínezSuárez V, Moreno-Villares JM, Collado-Yurrita LR, HernándezCabria M, Morán-Rey FJ. Revisión Documento de Consenso: importancia nutricional y metabólica de la leche. Nutr Hosp 2015; 31 (1):92-101.
52. Radilla-Vázquez CC, Gutiérrez-Tolentino R, Vega Y León S, Radilla-Vázquez M, Coronado-Herrera M, Del Muro Delgado R. Intervention for the promotion on the consumption of milk and dairy products as a strategy to reduce overweight in adolescents of México Nutr Hosp 2019 Jul 1; 36(3):526-537.
53. Beaudry KM, Devries MC. Nutritional strategies to combat type 2 diabetes in aging adults: the importance of protein. Front Nutr 2019; 6: 138.
54. Pérez-Díaz I. Diabetes mellitus. Gac Med Mex 2016; 152 Suppl 1:50-5. Disponible en PubMed: www.anmm.org.mx.
55. El FTO, un gen vinculado a la obesidad, inhibe la sensación de saciedad. Sociedad Chilena de Obesidad. Disponible en: https://www.sochob.cl/web/el-fto-un-gen-vinculado-a-la-obesidad-inhibe-la-sensacion-de-saciedad/.
56. Yoon MS. The emerging role of branched-chain amino acids in insulin-resistance and metabolism. Nutrients 2016 Jul 1; 8 (7).
57. Rice BH, Quann EE, Miller GD. Meeting and exceeding dairy recommendations: effects of dairy consumption on nutrient intakes and risk of chronic disease. Nutr Rev 2013; 71:209-223.
58. Kim Y, Je Y. Dairy consumption and risk of metabolic syndrome: a meta-analysis. Diabet Med 2016; 33.
59. Shin S, Lee HW, Kim CE, et al. Association between milk consumption and metabolic syndrome among korean adults: results from the Health Examinees Study. Nutrients 2017; 9:1102.
60. Galvão-Cândido F, Silva-Ton WT, Gonçalves-Alfenas RC. Dairy products consumption versus type 2 diabetes prevention and treatment; a review of recent findings from human studies. Nutr Hosp 2013; 28(5):1384-1395.
61. Forman MR, Hursting SD, Umar A, Barrett JC. Nutrition and cancer prevention. A multidisciplinary perspective on human trials. Ann Rev Nutr 2004; 24:223-54. Doi: 10.1146/annurev. nutr.24.012003.132315.
62. Melnik B, Malte John S, Carrera-Bastos P, et al. The impact of cow´s milk-mediated mTORC1- signaling in the initiation and progression of prostate cáncer. Nutrition & Metabolism 2012; 9; 74.
63. Jeyaraman MM, Abou-Setta AM, Grant L, et al. Dairy product consumptionand development of cancer: an overview of reviews. BMJ Open 2019; 9: e023625. doi: 10.1136/bmjopen-2018-023625.
64. https://www.wcrf.org/dietandcancer/prostate-cancer. Acces: agosto de 2019.
65. Globocan. Prostate cancer incidence and mortality worldwide in 2008 summary. 2008. Disponible en: http://globocan.oarc. fr/factsheets/cancers/prostate.asp.
66. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, Morrison H, Sonawane B, Shifflett T, et al. Human prostate cancer risk factors. Cancer 2004; 101: S2371-S2490.
67. Ganmaa D, Li XM, Wang J, Qin LQ, Wang PY, Sato A. Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Int J Cancer 2002; 98:262-267.
68. Colli JL, Colli A. International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urol Oncol 2006; 24:194-194.
69. Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. Journal of the National Cancer Institute 2005; 97(23):1768-1777.
70. Qin L-Q, Xu J-Y, Wang P-Y, et al. Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Asia Pac J Clin Nutr 2007; 16 (3):467-476.
71. Giovannucci E, Liu Y, Platz E, Stampfer MJ, Willet WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007 October 1; 121(7): 1571-1578.
72. Aune D, Navarro-Rosenblat DA, Chan DSM, et al. Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies. Am J Clin Nutr 2015 Jan; 101(1):87-117. Doi: 10.3945/ajcn.113.067157.
73. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 2018; 103:356-87.
74. Giovannucci E, Liu Y, Stampfer MJ, Willett WC. A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15:203-210.
75. Song Y, Chavaroo JE, Cao Y, et al. Whole milk intake is associated with prostate cancer-specific mortality among U.S. Male physicians. J Nutr 2013; 143:189-196.
76. Vasconcelos A, Santos T, Ravasco P, Neves PM. Dairy products: Is there an impact on promotion of prostate cancer? A review of the literature. Front Nutr 2019; 6:62. Doi: 10.3389/ fnut.2019.00062.
77. Yang M, Kenfield SA, Van Blarigan EL, et al. Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality. Int J Cancer 2015; 137(10): 2462-2469. Doi:10.1002/ijc.29608.
78. Tat D, Kenfield SA, Cowan JE, et al. Milk and other dairy foods in relation to prostate cáncer recurrence: data from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE™). Prostate 2018 Jan; 78(1): 32-39. Doi:10.1002/pros.23441.
79. Torfadottir JE, Steingrimsdottir L, Mucci L, Aspelund T, Kasperzyk JL, Olafsson O, Fall K, Tryggvadottir L, Harris TB, Launer L, Jonsson E, Tulinius H, Stampfer M, Adami HO, Gudnason V, Valdimarsdottir UA. Milk intake in early life and risk of advanced prostate cancer. Am J Epidemiol 2012; 175:144-153.
80. Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Tjønneland A, Johnsen NF, Overvad K, Linseisen J, Ro rmann S, Boeing H, Pischon T, Bueno-de-Mesquita HB, Kiemeney L, Tagliabue G, Palli D, Vineis P, Tumino R, Trichopoulou A, Kassapa C, Trichopoulos D, Ardanaz E, Larrañaga N, Tormo MJ, Gonzá- lez CA, Quirós JR, Sánchez MJ, Bingham S, Khaw KT, Manjer J, Berglund G, Stattin P, Hallmans G, Slimani N, Ferrari P, Rinaldi S, Riboli E. Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2008; 98:1574-1581.
81. Lu W, Chen H, Niu Y, et al. Dairy products intake and cancer mortality risk: a meta-analysis of 11 population-based cohort studies. Nutrition Journal 2016; 15:91. Doi 10.1186/s12937-016-0210-9.
82. Rodríguez C, McCullough ML, Mondul AM, Jacobs EJ, Fakhrabadi-Shokoohi D, Giovannucci EL, Thun MJ, Calle EE. Calcium, dairy products, and risk of prostate cancer in a prospective cohort of the United States men. Cancer Epidemiol Biomarkers Prev 2003; 12:597-603.
83. Huncharek M, Muscat J, Kupelnick B. Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies. Nutr Cancer 2008; 60:421-441.
84. Ahunm J, Albanes D, Peters U, et al. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2007; 16(12):2623-30.
85. Harrison S, Lennon R, Holly J, et al. Does milk intake promote prostate cancer initiation or progression via efects on insulinlike growth factors (IGFs)? A systematic review and metaanalysis. Cancer Causes Control 2017; 28:497-528.
86. Melnik B, Schmitz G. Exosomas of pasteurized milk: potential pathogens of Western diseases. Journal of Traslational Medicine 2019; 17:3.
87. Qin LQ, Wang PY, Kaneko T, Hoshi K, Sato A. Estrogen: one of the risk factors in milk for prostate cancer. Med Hypotheses 2004; 62:133-142.
88. Fekete ÁA, Givens DI, Lovegrove JA. Can milk proteins be a useful tool in the management of cardiometabolic health? An updated review of human intervention trials. Proc Nutr Soc. 2016 Aug; 75(3):328-41. Epub 2016 May 6.
89. Mullie P, Pizot C, Autier P. Daily milk consumption and allcause mortality, coronary heart disease and stroke: a systematic review and meta-analysis of observational cohort studies. BMC Public Health 2016; 16:1236.
90. Sabita S, Soedamah-Muthu, Janette de Goede. Dairy consumption and cardiometabolic diseases: systematic review and updated meta-Analyses of prospective cohort studies. Curr Nutr Rep 2018 Dec; 7(4):171-182.
91. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010 Mar; 91(3):535-46. Epub 2010 Jan 13.
92. Guo J, Astrup A, Lovegrove LA, Gijsbers L. Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. European Journal of Epidemiology 2017; 32(4).
93. Lordan R, Tsoupras A, Mitra B, Zabetakis I. Dairy fats and cardiovascular disease: Do we really need to be concerned? Foods 2018 Mar; 1,7(3).
94. Alexander DD, Bylsma LC, Vargas A, Cohen SS, Doucette A, Mohamed M, Irvin SR, Miller PE, Watson H, Fryzek JP. Dairy consumption and CVD: a systematic review and meta-analysis. Br J Nutr 2016 Feb 28; 115(4):737-50. Epub 2016 Jan 20.
95. Misselwitz B, Butter M, Verbeke K, Fox MR. Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut 2019 Nov; 68(11):2080-2091.
96. Fassio F, Facioni MS, Guagnini F. Lactose maldigestion, malabsorption, and intolerance: a comprehensive review with a focus on current management and future perspectives. Nutrients 2018 Nov 1; 10(11).
97. Storhaug CL, Fosse SK, Fadnes LT. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2017 Oct; 2(10):738-746.
98. Saborido R, Leis R. Yogurt and dietary recommendations for lactose intolerance Nutr Hosp 2018 Sep 7; 35 (Spec Nº 6):45-48.
99. Ugidos-Rodríguez S, Matallana-González MC, Sánchez-Mata MC. Lactose malabsorption and intolerance: a review. Food Funct 2018 Aug 15; 9(8):4056-4068.
100. Szilagyi A, Ishayek N. Lactose intolerance, dairy avoidance, and treatment options. Nutrients 2018 Dec; 15:10(12).
101. González-Hernández N, López-Robles GA. Parte 1: Alergia a la proteína de leche de vaca. Acta Pediátrica Hondureña 2016; Vol. 7, Nº 1.
102. Agostoni C, Turck D. Is cow's milk harmful to a child's health? Journal of Pediatric Gastroenterology and Nutrition 2011; 53(6):594-600.
103. Plaza-Martín AM. Alergia a proteínas de leche de vaca. Protoc Diagn Pediatr 2013; 1:51-61.
104. Marrs T, Flohr C. ¿Cómo influye la microbiota en el desarrollo del eczema y la alergia alimentaria? The Pediatric Infectious Disease Journal 2016; Vol 35, Nº 11.
105. Lifschi C, Szajewska H. Cow's milk allergy: evidence-based diagnosis and management for the practitioner. European Journal of Pediatric Feb 2015; Vol 174, Issue 2:141-150.




IMPORTANCE OF MILK AND ITS POTENTIAL EFFECTS ON HUMAN HEALTH

SUMMARY

The Argentine Food Code establishes: ""With the denomination of milk without any qualification, it is understood the product obtained by the total and uninterrupted milking, in hygienic conditions, of the dairy cow in good state of health and feeding, coming from registered milking yards and enabled by the Jurisdictional Bromatological Health Authority and without additives of any kind""1. Cow's milk is a quantitatively useful component in human food largely due to widespread access from its industrialization and commercialization. Its composition makes it of interest to adapt its use and prescription at different times of life and in the promotion of health. According to research studies, the effects would not be limited exclusively to their nutritional value, but would add other potentials in certain pathologies such as cardiovascular disease, some types of cancer, high blood pressure, bone or dental pathology and in the fight against Overweight and obesity. For this reason, the Food Working Group of the Argentine Nutrition Society conducted this review on the potential effects of milk: virtuous or adverse.

Key words: milk; potential effects.



DESCARGAR TEXTO COMPLETO EN PDF